Universal Q4 Earnings Call Highlights

• 2 Stocks to Watch arsenic the Quantum Space Gets More Crowded

Universal (NYSE:UVV) said its fiscal 2026 results were pressured by a non-cash goodwill impairment successful its ingredients concern and higher inventory write-downs tied chiefly to non-wrapper acheronian air-cured tobacco, adjacent arsenic absorption described the company’s halfway flue-cured and burley baccy operations arsenic solid.

Chairman, President and CEO Preston D. Wigner told investors connected the company’s fourth-quarter net telephone that Universal operated successful a marketplace that “shifted meaningfully from the anterior year,” with oversupply successful definite baccy styles and continued headwinds successful ingredients weighing connected volumes and margins.

→ Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move

• The Trade Desk Raised Forecasts Means Ad Spending is Back, Maybe

“Our fiscal twelvemonth 2026 show reflected coagulated execution crossed overmuch of our business,” Wigner said. “However, our fiscal results for the 4th fourth and fiscal twelvemonth were impacted by a non-cash goodwill impairment related to our Universal Ingredients Shank’s cognition and by inventory write-downs chiefly related to non-wrapper acheronian air-cured tobacco.”

Fourth-quarter gross rose, but net fell

Chief Financial Officer Steven S. Diel, who was appointed to the relation effectual April 1, said consolidated gross for the 4th fourth was $715 million, up 2% from the aforesaid play a twelvemonth earlier. Full-year consolidated gross was $2.9 billion, down somewhat from what Diel called an “exceptional” fiscal 2025.

→ Quantum Stocks Just Got a Lifeline—Who Benefits Most?

• Disney Stock Analysis, Insights and Outlook

The institution reported a fourth-quarter operating nonaccomplishment of $15 million, compared with operating income of $43 cardinal successful the prior-year quarter. For the afloat year, operating income fell to $169 cardinal from $233 cardinal successful fiscal 2025.

Net nonaccomplishment attributable to Universal was $43 cardinal successful the 4th quarter, compared with nett income of $9 cardinal a twelvemonth earlier. Full-year nett income declined to $33 cardinal from $95 cardinal successful fiscal 2025.

→ Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy?

Diel said the little net were driven chiefly by 2 factors: weaker profitability and a $41 cardinal non-cash goodwill impairment astatine Shank’s wrong the ingredients segment, and higher inventory write-downs on with weaker show successful the non-wrapper acheronian air-cured baccy business.

Tobacco conception deed by acheronian air-cured write-downs

Universal’s baccy conception generated fourth-quarter gross of $632 million, up 3% from the prior-year quarter. For the afloat year, baccy gross was $2.6 billion, down somewhat from fiscal 2025.